Risk factors

Alpha Metallurgical Resources faces intense concentration risk, with 78% of revenues from coal exports and 97% from metallurgical coal in 2024. The company depends heavily on a small customer base, with its largest customer representing 16% and top 10 customers 75% of revenues. Substantial long-term liabilities include $100.6 million in pension obligations, $114.3 million in black lung obligations, and $53.5 million in workers' compensation.

Ameresco relies heavily on government contracts and environmental attribute sales, exposing it to public sector health and policy shifts.

Amneal Pharmaceuticals relies heavily on four major customers representing seventy percent of net sales and carries two point six billion dollars in debt. The company faces intense generic and brand competition, concentration risks in product families and manufacturing sites, and rigorous regulatory oversight.

Workers compensation insurer AMERISAFE faces risks centered on loss reserve adequacy, cyclical industry pricing, and macroeconomic impacts on hazard-heavy policyholder industries.

IAC controls the company with 98.3% voting power, creating significant governance and conflict risks.

Acquisition of Alimera introduces new ophthalmic products, international operations, and third-party manufacturing dependencies.

Artivion relies heavily on tissue preservation services, BioGlue, aortic stent grafts, and On-X products for its revenues. Operations face strict regulatory scrutiny regarding medical devices, human tissues, and sterilization processes like EtO. Growth depends on ongoing clinical studies, regulatory approvals, and international expansion.

APA's risks are heavily concentrated on volatile commodity prices, operational and geopolitical exposures in Egypt and the U.K., and regulatory shifts related to environmental and energy transition pressures.

Axon relies heavily on law enforcement agencies purchasing its CED devices and software subscriptions. Government procurement cycles, budgets, and open bidding create significant sales volatility. International expansion and AI adoption introduce new regulatory and operational complexities.

This initial risk filing is dominated by regulatory compliance, interest rate exposure, and real estate loan concentrations.

BBSI faces heavy geographic concentration risk, with approximately 72 percent of total revenues derived from California operations in 2024. The company depends heavily on maintaining workers' compensation insurance coverage and managing workplace injury severity. Regulatory compliance across complex employment, tax, and healthcare frameworks heavily dictates operational success.

Bel Fuse faces heavy operational exposure in China, with 41 percent of associates and 62 percent of facilities located there. The November 2024 acquisition of Enercon added significant leverage, defense market concentration, and operations in Israel. Global manufacturing across multiple jurisdictions creates complex exposure to tariffs, trade restrictions, and shifting environmental regulations.